Sales decline 15.49% to Rs 10.80 crore
Net profit of Concord Drugs reported to Rs 0.23 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales declined 15.49% to Rs 10.80 crore in the quarter ended December 2024 as against Rs 12.78 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales10.8012.78 -15 OPM %12.874.93 -PBDT0.900.13 592 PBT0.53-0.26 LP NP0.23-0.24 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content